The team does not plan to place Daniels on IR at this point. Instead, it will reassess his health after its Week 12 bye.
Medpage Today on MSN
Year in Review: Breast Cancer
The findings came from analyses of two national cancer registries. ILC accounts for about 10% of all newly diagnosed breast ...
Jelly Roll sported a nearly flat stomach, and a top plastic surgeon explains the procedures that could had giving him that ...
Medpage Today on MSN
Saroglitazar for MASLD Cuts Liver Fat in Women With Polycystic Ovary Syndrome
WASHINGTON -- Daily treatment with the novel drug saroglitazar significantly reduced liver fat in women with metabolic ...
The drug, delivered by EMS as a single injection, improved infarct-related patency at cath lab arrival and 30-day clinical outcomes.
Good afternoon, ladies and gentlemen, and welcome to the Inovio Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] This call is being recorded on Monday, November 10, 2025.
UniQure stock dropped after the FDA sent feedback on the company's pending treatment for Huntington's disease. Read more on ...
Total Revenue -- $86,000 was recognized in the third quarter from initial sales of nPulse Capital and Vibrance disposables ...
Avisi Technologies has released positive 12-month clinical data on the VisiPlate Aqueous Shunt from the VITA Trial. The VITA ...
Excerpts from recent editorials in the United States and abroad: ___ Nov. 9 The Washington Post says TrumpRx isn't the best way to lower prices In a landmark deal announced Thursday, President Donald ...
The small-profile device expands to capture clots like large-bore systems while offering good reduction in RV/LV ratio at 48 ...
Operator: Hello, and thank you for standing by. My name is Mark, and I will be your conference operator today.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results